KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Research & Development (2021 - 2025)

Historic Research & Development for Hims & Hers Health (HIMS) over the last 5 years, with Q3 2025 value amounting to $40.6 million.

  • Hims & Hers Health's Research & Development rose 9238.1% to $40.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.1 million, marking a year-over-year increase of 9289.96%. This contributed to the annual value of $78.8 million for FY2024, which is 6343.33% up from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's Research & Development is $40.6 million, which was up 9238.1% from $37.8 million recorded in Q2 2025.
  • Hims & Hers Health's 5-year Research & Development high stood at $40.6 million for Q3 2025, and its period low was $5.6 million during Q4 2021.
  • Over the past 5 years, Hims & Hers Health's median Research & Development value was $12.3 million (recorded in 2023), while the average stood at $16.3 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 2779.56% in 2022, then soared by 10289.48% in 2025.
  • Quarter analysis of 5 years shows Hims & Hers Health's Research & Development stood at $5.6 million in 2021, then skyrocketed by 49.16% to $8.3 million in 2022, then surged by 61.29% to $13.4 million in 2023, then skyrocketed by 77.17% to $23.7 million in 2024, then skyrocketed by 70.86% to $40.6 million in 2025.
  • Its last three reported values are $40.6 million in Q3 2025, $37.8 million for Q2 2025, and $29.9 million during Q1 2025.